Last reviewed · How we verify

NCT05588232: VirtuCardio

the Effectiveness of Therapeutic Virtual Reality Versus Pharmacological Sedation on Pain and Anxiety During Interventional Cardiology Procedures

Completed NA Last updated 21 October 2022
What this trial tests

NA trial testing scheduled outpatient interventions in interventional cardiology in Virtual Reality in 136 participants. Completed in 24 February 2022.

Timeline
18 October 2021
Primary endpoint
11 December 2021
24 February 2022

Quick facts

Lead sponsorElsan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment136
Start date18 October 2021
Primary completion11 December 2021
Estimated completion24 February 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Elsan — full company profile →

Who can join

18 and older, any sex, with Virtual Reality or Drug Sedation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Immersion sedation in virtual reality could be an alternative to conventional pharmacological sedation, during interventional cardiology acts on pain and anxiety control. The objective of this study is to determine whether virtual reality immersion is non-inferior to drug sedation on pain and anxiety, during coronary angiography or angioplasty.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy of virtual reality therapy versus pharmacological sedation for reducing pain and anxiety during coronary catheterisation procedures: A prospective randomised controlled trial.
    Verain J, Trouillet C, Moulin F, Christophe C. · · 2024 · cited 3× · PMID 39355099 · DOI 10.1002/hsr2.2151

Verify or expand the search:

Other recruiting trials for Virtual Reality

Currently open trials in the same condition.

Other Elsan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05588232.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing